Bulletin: Bard (C.R.) Inc. Ratings Unchanged After Company Increases Its Commercial Paper Program Jan 12
- Language: English
- Published: January 2012
The ratings on Murray Hill, N.J.-based C.R. Bard Inc. reflect the company's strong business risk profile and modest financial risk profile. The ratings also overwhelmingly reflect the medical device manufacturer's solid position across several business segments, its cash flow, and strong liquidity. Bard's strong business risk profile is supported by its solid market-share positions across oncology, surgical, urology, and vascular product markets, with a particular strength in urology catheters and specialty access products. The company derives the majority of revenues from products for which it has a No. 1- or No. 2-market share, and the company is not overly reliant on any particular device for its revenues. However, the ratings also reflect potential competitive pressures from other manufacturers and stagnant...
Companies mentioned in this report are: Bard (C.R.) Inc.
Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.
This product consists of a Summary Analysis: Bi-annual (at least). An abbreviated analysis containing Standard & Poor's issuer credit ratings as of the time the article was published. The analysis includes a rating rationale - the basis on which the rating was assigned - and an outlook section if the issuer is not on CreditWatch. Financial statistics are not included.
SHOW LESS READ MORE >